HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nick Pantaleo Selected Research

Exenatide (Byetta)

9/2012Euglycemic agent-mediated hypothalamic transcriptomic manipulation in the N171-82Q model of Huntington disease is related to their physiological efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nick Pantaleo Research Topics

Disease

1Disease Progression
09/2012
1Nervous System Diseases (Neurological Disorders)
11/2010
1Obesity
11/2010
1Sleep Wake Disorders
11/2010
1Machado-Joseph Disease (Spinocerebellar Ataxia Type 3)
11/2010
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2010
1Cognitive Dysfunction
11/2010
1Alzheimer Disease (Alzheimer's Disease)
11/2010
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
11/2010

Drug/Important Bio-Agent (IBA)

1Insulin (Novolin)FDA Link
09/2012
1Exenatide (Byetta)FDA Link
09/2012
1LigandsIBA
11/2010
1NeuropeptidesIBA
11/2010
1TachykininsIBA
11/2010
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2010
1GhrelinIBA
11/2010
1Ghrelin ReceptorsIBA
11/2010